Glen Eagle Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-100
| Closed | -$219 | – | 821 |
|
|
2019
Q2 | $219 | Hold |
100
| – | – | ﹤0.01% | 786 |
|
|
2019
Q1 | $599 | Hold |
100
| – | – | ﹤0.01% | 718 |
|
|
2018
Q4 | $739 | Hold |
100
| – | – | ﹤0.01% | 692 |
|
|
2018
Q3 | $1.45K | Hold |
100
| – | – | ﹤0.01% | 652 |
|
|
2018
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 612 |
|
|
2018
Q1 | $1.75K | Hold |
100
| – | – | ﹤0.01% | 602 |
|
|
2017
Q4 | $2.47K | Buy |
+100
| New | +$2.47K | ﹤0.01% | 561 |
|